Epsilon M&A Deal Report - Laboratoire de la Mer SASU
Transaction Multiples for the Valuation of Private Companies
Omega Pharma / Laboratoire de la Mer SASU
No EMAT :
22900
Announced Date :
29/09/2010
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Omega Pharma
Target :
Laboratoire de la Mer SASU
Country :
France
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Personal Products
Business Description :
Laboratoire de la Mer develops and markets all-natural OTC health products that target the ‘respiratory tract’ market . The company's products include nasal, ear, oral and dental, and eye care, as...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
||
| Current |
|
|
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
- Number of EMAT Reports / sub-sector « Personal Products » = 134
| Date | Acquirer | Target | Country | Multiples | See details |
| 11/02/2011 | Private Group led by CIC LBO Partners | Assistances Médicales Spécialisées (AMS) | France | * | 22875 |
| 23/12/2008 | Eckert & Ziegler Strahlen Und Medizintechnik (EZAG) | Nuclitec | Germany | ** | 22817 |
Source: Epsilon Research / EMAT
